CD8A and cancer: To explore the contribution of TAM subsets in NSCLC, we analyzed the cellular interactions between TAMs with cancer cells and CD8+ T cells, based on the differentially expressed TAM ligands [False Discovery Rate (FDR) < 0.01, absolute log2FC > 1].